Results 51 to 60 of about 251,509 (278)

Respiratory-syncytial virus immunoprophylaxis on asthma symptoms development in prematurity with bronchopulmonary dysplasia

Journal of Allergy and Clinical Immunology: Global, 2023
Background: Infants with respiratory-syncytial virus bronchiolitis hospitalization are more likely to develop wheezing and subsequent asthma. Reportedly, palivizumab prophylaxis effectively prevents respiratory-syncytial virus hospitalization in high ...
Li-Ching Fang, MD, Jen-Yu Wang, MD, Hsin-Hui Yu, MD, PhD, Li-Chieh Wang, MD, PhD, Bor-Luen Chiang, MD, PhD   +4 more
doaj  

Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein [PDF]

, 2014
Infections with human respiratory syncytial virus (HRSV) occur globally in all age groups and can have devastating consequences in young infants. We demonstrate that a vaccine based on the extracellular domain (SHe) of the small hydrophobic (SH) protein ...
Bert Schepens, Brian Gilbert, Cherrie AH, Connors M, Glezen WP, Kenny Roose, Koen Sedeyn, Liesbeth Vande Ginste, Lieselot Houspie, Marc Van Ranst, Michael Schotsaert, Mills JT, Nicholas JA, Nico Rooijen, Olmsted RA, Pedro Piedra, Sarah De Baets, Ventre K, Walter Fiers, Whitehead SS, Xavier Saelens   +20 more
core   +3 more sources

Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study

European Respiratory Journal, 2020
Respiratory syncytial virus (RSV) infection in older adults is recognised, but the burden in the community is still uncertain. This European study found that RSV infection is prevalent but rarely caused severe disease in community-dwelling older adults ...
K. Korsten, N. Adriaenssens, S. Coenen, C. Butler, Behnaz Ravanfar, H. Rutter, Julie Allen, A. Falsey, J. Pirçon, O. Gruselle, V. Pavot, Charlotte Vernhes, S. Balla-Jhagjhoorsingh, Deniz Öner, G. Ispas, J. Aerssens, V. Shinde, T. Verheij, L. Bont, J. Wildenbeest   +19 more
semanticscholar   +1 more source

Pre-existing virus-specific CD8+ T-cells provide protection against pneumovirus-induced disease in mice [PDF]

, 2012
Pneumoviruses such as pneumonia virus of mice (PVM), bovine respiratory syncytial virus (bRSV) or human (h)RSV are closely related pneumoviruses that cause severe respiratory disease in their respective hosts.
Alice J.A.M. Sijts, Alwan, Andrea Gröne, Andrew J. Easton, Bossert, Braciale, Buchholz, Cannon, Castilow, Chang, Chen, Chin, Claassen, Claassen, Claire J.P. Boog, Cornelis P.J. Bekker, David J. Topham, Dietmar M.W. Zaiss, Dirk H. Busch, Easton, Falsey, Fenton, Frey, Fulginiti, Garvey, Graham, Hall, Heinze, Henderson, Hussell, Kapikian, Kim, Kruijsen, Kulkarni, Lo, Mary J.G. van Helden, Ostler, Ostler, Percopo, Peter J.S. van Kooten, Piedra, Polakos, Rosenberg, Rosenberg, Sherman, Srikiatkhachorn, Stevens, Stevens, Thompson, Tregoning, Varga, Zaiss   +51 more
core   +1 more source

Respiratory syncytial virus

Uirusu, 2005
Human respiratory syncytial virus (RSV) is the most common worldwide cause of lower respiratory tract infections (LRI) in infants less than 6 months of age. The prophylaxis against RSV infection by vaccination has been unsuccessful because of its adverse effects.
openaire   +5 more sources

Respiratory Syncytial Virus [PDF]

, 2013
Name of Virus: Respiratory Syncytial ...
Armando E. Fraire, Bruce A. Woda
openaire   +1 more source

Age-dependent differences in the pathogenesis of bovine respiratory syncytial virus infections related to the development of natural immunocompetence [PDF]

, 2010
The severity of respiratory syncytial virus (RSV) infections appears to differ with age in both humans and bovines. A primary RSV infection in naïve infants and in young calves runs a more severe course when they are 1–6 months old than in their first ...
Antonis, A.F.G., Jong, M.C., de, Kimman, T.G., Most, R.G., van der, Poel, W.H.M., van der, Schrijver, R.S., Stockhofe-Zurwieden, N.   +6 more
core   +2 more sources

The impact of COVID-19 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter

Clinical Infectious Diseases, 2020
Public health measures during the COVID-19 pandemic have potential to impact transmission of other respiratory viruses. We found 98.0% and 99.4% reductions in RSV and influenza detections respectively in Western Australian children through winter 2020 ...
D. Yeoh, D. Foley, C. Minney-Smith, Andrew C Martin, A. Mace, C. Sikazwe, Huong Le, A. Levy, C. Blyth, H. Moore   +9 more
semanticscholar   +1 more source

An Overview of Respiratory Syncytial Virus

PLoS Pathogens, 2014
Respiratory Syncytial Virus (RSV), a member of the Paramyxoviridae family, is the leading cause of lower respiratory tract illness (LRI) in infants. From 1993 to 2008, the total RSV hospitalization rate in the United States across all age groups was 55 per 100,000 person-years, slightly lower than the rate of 64 per 100,000 personyears for influenza ...
Anne L. Hotard, Jia Meng, Christopher C. Stobart, Martin L. Moore   +3 more
openaire   +4 more sources

Kinetics of the neutralizing antibody response to respiratory syncytial virus infections in a birth cohort [PDF]

, 2013
The kinetics of respiratory syncytial virus (RSV) neutralizing antibodies following birth, primary and secondary infections are poorly defined. The aims of the study were to measure and compare neutralizing antibody responses at different time points in ...
Cane, Patricia, Medley, Graham, Mutunga, M. N., Nokes, D. James, Okiro, Emelda A., Sande, Charles J.   +5 more
core   +1 more source